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Abstract
NOD2, the nucleotide-binding domain and leucine-rich repeat containing gene family (NLR) member 2 is involved in
mediating antimicrobial responses. Dysfunctional NOD2 activity can lead to severe inflammatory disorders, but the
regulation of NOD2 is still poorly understood. Recently, proteins of the tripartite motif (TRIM) protein family have emerged
as regulators of innate immune responses by acting as E3 ubiquitin ligases. We identified TRIM27 as a new specific binding
partner for NOD2. We show that NOD2 physically interacts with TRIM27 via the nucleotide-binding domain, and that NOD2
activation enhances this interaction. Dependent on functional TRIM27, ectopically expressed NOD2 is ubiquitinated with
K48-linked ubiquitin chains followed by proteasomal degradation. Accordingly, TRIM27 affects NOD2-mediated pro-
inflammatory responses. NOD2 mutations are linked to susceptibility to Crohn’s disease. We found that TRIM27 expression is
increased in Crohn’s disease patients, underscoring a physiological role of TRIM27 in regulating NOD2 signaling. In HeLa
cells, TRIM27 is partially localized in the nucleus. We revealed that ectopically expressed NOD2 can shuttle to the nucleus in
a Walker A dependent manner, suggesting that NOD2 and TRIM27 might functionally cooperate in the nucleus. We
conclude that TRIM27 negatively regulates NOD2-mediated signaling by degradation of NOD2 and suggest that TRIM27
could be a new target for therapeutic intervention in NOD2-associated diseases.
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Introduction
Innate immune responses are characterized by recognition of
invariant structural signatures of pathogens, so called pathogen-
associated molecular patterns (PAMPs) as well as the recognition
of danger-associated molecular patterns (DAMPs), which generally
are compartmentalized host molecules that delocalize upon cell
damage. Different types of pattern-recognition receptors (PRRs)
show distinct subcellular localizations to recognize extracellular,
vesicular or cytosolic PAMPs and DAMPs. NOD2 is a member of
the nucleotide-binding domain and leucine-rich repeat containing
protein family (NLR), many of which are important cytosolic
PRRs [1–3]. NOD2 is composed of two N-terminal CARD
domains recruiting the downstream signaling adaptor RIP2, a
central nucleotide-binding domain (NBD) thought to mediate
homooligomerization and a C-terminal leucine-rich repeat
domain likely involved in pattern recognition. It is localized to
the cytoplasm but is also partially found at the plasma membrane
[4–7]. NOD2 induces signaling cascades in response to muramyl
dipeptide (MDP), a bacterial peptidoglycan fragment, which
activates NF-kB and MAP kinases and finally results in the
transcription of proinflammatory cytokines, chemokines and
antimicrobial peptides [8–10].
NOD2 gain-of-function mutations leading to uncontrolled NF-
kB activation are found in severe autoinflammatory disorders like
early-onset sarcoidosis (EOS) and Blau syndrome (BS) [11],
underscoring the need to tightly regulate NOD2 activation. Other
mutations in NOD2, predominantly fs1007, are linked with the
development of Crohn’s disease (CD), a multifactorial inflamma-
tory bowel disease [11]. These mutations are located in the LRR-
domain and result in a loss-of-function for MDP sensing. Several
proteins like the cell polarity protein Erbin [4,12], the GTPase-
activating protein Centaurin-b1 (CENTB1) [13], and the angio-
associated migratory cell protein (AAMP) [14] have been shown to
bind NOD2 and negatively regulate NOD2-mediated NF-kB
activation. However, the contribution of NOD2 protein turn-over
on signaling has not been elucidated.
Tripartite motif-containing (TRIM) proteins are present in all
metazoans and over 60 TRIM proteins are encoded in the human
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genome [15]. They are involved in a broad range of biological
processes including cell proliferation, differentiation, development,
morphogenesis, and apoptosis and many TRIM proteins are
expressed in response to interferons (IFNs) [16,17]. Members of the
TRIM protein superfamily possess a RBCC motif at the N-terminus,
which consists of a RING domain and one or two B-Box domains
followed by a coiled-coil region. They differ from each other by their
C-terminal domain. Most TRIM family members are, however,
characterized by a PRY-SPRY (also called B30.2) domain which is
suggested to serve as target binding site [18,19]. RING domains
mediate the conjugation of proteins with ubiquitin, SUMO or ISG15
[20,21] and E3 ubiquitin ligase activity has been observed for several
TRIM proteins. Recently, members of the TRIM family have been
implicated in regulating antiviral and antimicrobial immune
responses. The importance of TRIM proteins in regulating immune
homeostasis is highlighted by inherited disorders that are associated
with some of these genes: TRIM20 (pyrin) is mutated in the
inflammatory disease familial Mediterranean fever (FMF) [22,23]
and TRIM21 (Ro52) is one of the autoantigens detected in Sjo¨gren’s
syndrome (SS) and systemic lupus erythematosus (SLE), two severe
autoimmune disorders [24,25]. The most prominent example for
antiviral activities of TRIM proteins is provided by TRIM5-a which
is necessary to restrict retroviral infection in mammals, and in
particular in higher primates [26].
TRIM27 (alternatively named RET finger protein (RFP)) is a
member of the TRIM superfamily and exhibits the classical PRY-
SPRY domain C-terminal of the RBCC motif. TRIM27 was
initially identified as a part of the rfp/ret transforming gene
generated by DNA rearrangements, in which the RING finger is
essential for the oncogenic potential [27]. In accordance with the
presence of a RING finger, TRIM27 has been shown to confer E3
ubiquitin ligase activity with the enzymes UBE2D1 and D3 [28]
and to possess SUMO E3 ligase activity [29]. TRIM27 is highly
expressed in mouse spleen and thymus [30] and in cells of the
hematopoietic compartment [16]. In contrast to many other TRIM
proteins, TRIM27 expression is not altered by type I and II IFNs
[16,17]. TRIM27 exhibits either nuclear or cytosolic localization
depending on the cell type [30,31]. Like other TRIM proteins,
TRIM27 can form homooligomers mediated by the coiled-coil
domain [31]. Heterooligomerization has been observed between
TRIM27 and TRIM19 with the recruitment of the former to
promyelocytic leukaemia nuclear bodies (PMLs) [32]. Furthermore,
interaction with members of the protein inhibitors of activated
STAT (PIAS) family results in targeting of TRIM27 to subnuclear
compartments by TRIM27 SUMOylation [33]. A role for TRIM27
in transcriptional repression [34,35], the negative regulation of NF-
kB and IFN-signaling pathways [36], apoptosis [37], and in cell
cycle regulation [38] has been reported, suggesting that TRIM27 is
involved in the control of multiple cellular processes.
Here we show that TRIM27 regulates innate immune responses
by physical interaction with NOD2. We find that TRIM27
mediates K48-linked ubiquitination and subsequent proteasomal
degradation of NOD2. Functionally, TRIM27 negatively influ-
enced NOD2-mediated NF-kB activation. TRIM27 expression
was enhanced in Crohn’s patients, indicating a physiological role
of TRIM27 in controlling NOD2 activity. Of note, ectopically
expressed NOD2 colocalized with TRIM27 to the nucleus of
HeLa cells, suggesting a new role for NOD2 in nuclear processes.
Results
TRIM27 is a new interaction partner of NOD2
Members of the TRIM protein family are emerging as
important new regulators of innate immune responses. We were
interested in whether TRIM proteins also contribute to NOD2
signaling. To search for TRIM proteins that physically interact
with human NOD2, we conducted a yeast two-hybrid screen with
a panel of human TRIM proteins as bait and NOD2 as prey. This
identified interactions of NOD2 with TRIM8, TRIM27, and
TRIM50 (Figure S1A). Of note, we observed homointeractions for
all TRIM proteins indicating a correct folding [39]. Furthermore,
TRIM27 formed heterointeractions with TRIM8 and TRIM18
(Figure S1A). Next, we verified interactions of NOD2 with
TRIM8, TRIM27, and TRIM50. To this end, co-immunopre-
cipitations in human embryonic kidney (HEK293T) cells express-
ing Flag-NOD2 and myc-tagged TRIM proteins were performed.
We observed interaction of NOD2 with TRIM27 (Figure 1A), but
no robust interaction with the other TRIM proteins tested could
be detected (data not shown). Importantly, NOD2 had a much
higher binding affinity for TRIM27 than NOD1 (Figure 1A, 1B),
which was confirmed by reciprocal co-immunoprecipitations
(Figure 1B), suggesting specificity of the interaction.
To establish this interaction for endogenous TRIM27, we
transfected HEK293T cells, which strongly express TRIM27
(Figure S2A), with Flag-NOD2 and immunoprecipitated NOD2.
This revealed that also endogenous TRIM27 co-precipitated with
NOD2 but not with the matrix alone (Figure 1C). Moreover,
endogenous TRIM27 also bound endogenous NOD2 precipitated
with the NOD2 specific antibody 6F6 (Figure S1B) from the colon
cell line SW480 (Figure 1D). NOD2 is activated by MDP, a
bacterial peptidoglycan fragment. To explore whether activation
of NOD2 has an influence on NOD2-TRIM27 complex
formation, we treated Nod2-expressing HEK293T cells with
MDP prior to lysis. This revealed that NOD2 activation slightly
increased its interaction with TRIM27 (Figure 1D).
To obtain additional in vitro evidence for the NOD2-TRIM27
interaction and to elucidate the necessary TRIM27 domain for
interaction, we next performed protein-protein interaction assays.
To this end, in vitro-transcribed and -translated NOD2 was
incubated with recombinantly expressed, GST-tagged TRIM27
protein bound to glutathione-Sepharose. NOD2 strongly bound to
TRIM27 WT and TRIM27 DRING and to a weaker extent to
TRIM27 DRING+B-Box. Virtually no binding was observed to
GST alone, which was used as control (Figure 1E). As reticulocyte
lysates only contain a limited repertoire of endogenous proteins,
this finding strongly suggest that the NOD2-TRIM27 interaction
is direct. Collectively, these findings established that TRIM27
physically interacts with NOD2 in human cells.
TRIM27 PRY-SPRY and NOD2 NBD domains are sufficient
for interaction
In order to elucidate the protein domains that mediate NOD2-
TRIM27 interaction in more detail, we performed a series of co-
immunoprecipitation experiments with NOD2 deletion mutants
lacking the two CARD domains (DCARDs) or the LRRs (DLRR),
or comprising only the CARD (CARDs) or NBD (NBD) domains
(depicted in Figure 2A, upper panel). We found that NOD2
binding to TRIM27 was independent of the CARD domains and
the LRRs. Instead, NOD2 NBD was sufficient to mediate the
interaction (Figure 2A, lower panel). Of note, TRIM27 binding to
NOD2 DLRR appeared to be stronger than to NOD2 WT. Next,
we determined which domains in TRIM27 are needed for NOD2
binding. In agreement with our in vitro data (Figure 1E), deletion
of the RING or both RING and B-Box domains did not abolish
the interaction with NOD2. In contrast, we did not observe
NOD2 binding to TRIM27 lacking the PRY-SPRY domain
(TRIM27 DPRY-SPRY) (Figure 2B, lower panel). However, the
expression of this construct was weak and we failed to obtain a
TRIM27 Regulates NOD2
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construct of this domain that expressed well in human cells. We
thus cannot formally exclude that NOD2 weakly binds to this
domain. However, we observed strong interaction of NOD2 with
the TRIM27 PRY-SPRY domain alone (Figure 2B, lower panel),
showing that the PRY-SPRY domain is sufficient for NOD2
binding.
TRIM27 contributes to NOD2 ubiquitination
To investigate if TRIM27 might be involved in ubiquitination
of NOD2, we first determined basal NOD2 ubiquitination status
in human cells. During expression in HEK293T cells, NOD2 but
not NOD1 was poly-ubiquitinated at steady-state conditions as
revealed by detection of conjugated HA-ubiquitin in immunopre-
cipitations of denatured lysates (Figure 3A). Using linkage-specific
anti-ubiquitin antibodies we showed that the NOD2 ubiquitin
chains reacted with an anti-K48-antibody (Figure 3B). Important-
ly, RIP2, a known NOD2-interacting protein that is ubiquitinated
upon NOD2 activation, did not significantly contribute to the
ubiquitin signal detected in the NOD2 precipitate, as shown by
siRNA-mediated depletion of RIP2 (Figure 3C). Recently,
TRIM27 was shown to interact with a subset of E2 enzymes
and to possess E3 ubiquitin ligase activity in vitro [28]. To
investigate if TRIM27 contributes to the ubiquitination of NOD2,
HEK293T cells were co-transfected with Flag-NOD2, myc-
TRIM27 WT and HA-ubiquitin. The ubiquitin signal in NOD2
precipitates, detected either by anti-HA or the K48-linkage-
specific antibody, was increased upon TRIM27 overexpression
Figure 1. NOD2 physically interacts with TRIM27 via the NBD domain. A–C) Lysates of HEK293T cells expressing the indicated proteins were
subjected to immunoprecipitation using anti-Flag (A and C) or anti-myc beads (B). Immunoblots of immunoprecipitates (IP) and total lysates (Input)
were performed using the indicated antibodies. D) Immunoprecipitation of endogenous NOD2 from SW480 cells using the NOD2- specific
monoclonal antibody 6F6. Cells were treated with 10 mM MDP for 3 h as indicated. Immunoblots of immunoprecipitates (IP) and total lysates (Input)
were performed using the indicated antibodies. E) Protein-protein binding assays using in vitro transcribed and translated [35S]-methionine-labeled
NOD2 and recombinant GST or GST-TRIM27 (WT, DRING or DRING+B-Box) bound to glutathione-Sepharose beads. The coomassie-stained gel
(bottom) and the autoradiograph (top) of co-precipitated NOD2 are shown.
doi:10.1371/journal.pone.0041255.g001
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(Figure 3D). In contrast, overexpression of a TRIM27 E3 ligase-
deficient mutant (called ‘TRIM27 E3’ here), in which the two
conserved catalytic cysteine residues within the TRIM27 RING
domain (C16 and C31) were mutated to alanine, significantly
reduced NOD2 ubiquitination compared to TRIM27 WT
(Figure 3D). Of note, TRIM27 E3 still bound NOD2 to the same
extent as TRIM27 WT, showing that this mutation did not affect
binding affinity (Figure 3D).
Since NOD2 activation by MDP seemed to increase the binding
affinity of the endogenous protein for TRIM27 (Figure 1D) we
went on to explore in more detail how activation of NOD2
influences NOD2-TRIM27 complex formation and NOD2
ubiquitination. To this end, we performed co-immunoprecipita-
tions in HEK293T cells expressing Flag-NOD2 and myc-TRIM27
following stimulation with 10 mM MDP at different time points.
MDP induced NOD2 activation as monitored by IkBa degrada-
tion (Figure 3E). Moreover, binding of TRIM27 to NOD2 was
enhanced over two-fold at 3 h after MDP stimulation compared to
untreated controls and accordingly we observed a stronger
ubiquitination of NOD2 after MDP treatment (Figure 3E).
Taken together, these data showed that NOD2 but not NOD1
is ubiquitinated and revealed a role for TRIM27 in this process,
which was dependent on activation of NOD2.
TRIM27 contributes to proteasomal degradation of NOD2
K48-linked ubiquitination of proteins usually targets them for
degradation by the 26S proteasome [40]. To investigate if NOD2
is subjected to proteasomal degradation, HEK293T cells express-
ing small amounts of Flag-NOD2 were treated with cycloheximide
(CHX) to block protein neosynthesis and changes in NOD2
protein levels were followed by immunoblot analysis. This showed
that NOD2 was readily degraded in a time-dependent manner
(Figure 4A, upper panel), whereas NOD1 was not subjected to
rapid protein turn-over (Figure S3A). TRIM27 WT overexpres-
sion only very slightly influenced the kinetic of NOD2 degradation
(Figures 4A, upper panel, and S3B). However, overexpression of
TRIM27 E3 strongly inhibited NOD2 degradation. This indicates
that TRIM27 E3 acts as dominant negative over TRIM27 WT
and endogenous TRIM27, which is expressed in these cells. To
determine whether NOD2 degradation occurred via the 26S
proteasome, we used the proteasome inhibitor bortezomib (MG-
341). NOD2 degradation was inhibited in HEK293T cells
expressing Flag-NOD2 treated with 100 nM bortezomib and
poly-ubiquitinated NOD2 was strongly accumulated as early as
3 h after bortezomib treatment (Figure 4B).
To elucidate the contribution of endogenous TRIM27 on
NOD2 degradation, TRIM27 expression was silenced in
HEK293T using two different TRIM27-specific siRNA duplexes.
Both siRNA duplexes reduced TRIM27 levels nearly to the
detection limit as shown by immunoblot (Figure 4C). In cells
transfected with non-targeting control siRNA NOD2 was readily
degraded after CHX treatment as observed before (Figure 4C). In
contrast, in cells treated with either of the two TRIM27-specific
siRNA duplexes, NOD2 degradation was effectively inhibited.
Figure 2. Mapping of the interaction domains in NOD2 and TRIM27. The depicted NOD2 (A) or TRIM27 (B) deletion constructs (upper panels)
were used for the domain mapping. Lysates were subjected to immunoprecipitation using anti-Flag beads and immunoblotted with the indicated
antibodies.
doi:10.1371/journal.pone.0041255.g002
TRIM27 Regulates NOD2
PLoS ONE | www.plosone.org 4 July 2012 | Volume 7 | Issue 7 | e41255
Figure 3. NOD2 is ubiquitinated. A) To determine NOD1 and NOD2 ubiquitination, denatured lysates of HEK293T cells expressing the indicated
proteins were subjected to immunoprecipitation. Immunoprecipitates were immunoblotted using the indicated antibodies B) To determine the type
of ubiquitin-linkage, lysates of HEK293T cells expressing the NOD1 or NOD2 were subjected to immunoprecipitation. Endogenous ubiquitin was
revealed using a K48-link specific antibody. C) HEK293T cells were transfected for 72 h with siCTR, siTRIM27-1 or -3 after expression of Flag-NOD2 and
HA-Ubiquitin. Immunoblots of immunoprecipitates (IP) and total lysates (Input) were performed using the indicated antibodies. D) TRIM27 and a E3
TRIM27 Regulates NOD2
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Taken together, these data revealed that K48-linked ubiquitina-
tion occurred on NOD2 and that this targeted NOD2 for 26S
proteasomal degradation in a TRIM27-dependent manner.
TRIM27 co-localized with ectopically expressed NOD2 in
the nucleus
In HeLa cells, TRIM27 has been shown to localize to the
nucleus [31], whereas in HEK293T cells TRIM27 is also found at
distinct sub-cellular structures (Figure S2B, S2C). NOD2 has been
shown to be a cytoplasmic protein that partially localizes to the
plasma membrane [4–6], whereas other NLR proteins such as
NLRC5 and CIITA also show nuclear localization [41–45]. We
asked if NOD2 might also be able to shuttle to the nucleus and co-
localize in this compartment with TRIM27 as previous experi-
ments indicated that transiently overexpressed NOD2 is some-
times found in the nucleus [4]. To investigate this in more detail,
we performed indirect immunofluorescence analysis in HeLa cells
transfected with myc-NOD2 WT and blocked nuclear export
using the specific nuclear export inhibitor leptomycin B (LMB). In
the untreated samples, NOD2 WT mainly localized to the cytosol
and was only partially found in the nucleus in less than 5% of the
cells (Figure 5A, 5B). After LMB treatment, however, NOD2 WT
was found in the nucleus in about 30% of the cells (Figure 5A, 5B).
In contrast, NOD1 and a NOD2 Walker A mutant (K305R),
which is unable to induce NF-kB activation [8], did not localize to
the nucleus at all, even after LMB treatment (Figure 5A and
Figure S2D). To substantiate these results, we prepared cytosolic
and nuclear fractions from HEK293T cells expressing either Flag-
NOD1, -NOD2 or -NOD2 K305R. Immunoprecipitation of the
Flag-tagged proteins from the cytosolic and nuclear fractions
revealed that a small portion of NOD2 was present in the nucleus
without LMB treatment (Figure 5C). NOD2 nuclear localization
was enhanced by about three-fold upon LMB treatment, as
determined by normalized densitometric analysis (Figure 5C),
which is in line with the data obtained in the cell-biological
analysis. In contrast, NOD1 and NOD2 K305R were again found
exclusively in the cytoplasm even after LMB treatment (Figure 5C).
Importantly, also untagged NOD2 showed a nuclear enrichment
after LMB treatment (Figure 5D), showing that nuclear localiza-
tion of NOD2 is not an artifact of the epitope tag used above. Of
note, the ability of NOD2 to trigger NF-kB activation upon MDP
stimulation was unaffected when NOD2 was targeted to the
nucleus by fusing it to a SV40 nuclear localization signal, showing
that nuclear localization of NOD2 is not detrimental to its
established function in bacterial sensing (data not shown).
Conclusively, our data show that at least ectopically expressed
NOD2 is able to shuttle to the nucleus in a Walker A-dependent
manner, which is reminiscent of the behavior of other NLRs, such
as NLRC5 and CIITA [41–45].
TRIM27 negatively influences NOD2 signaling
Finally, we wanted to determine the influence of TRIM27 on
NOD2-mediated signaling. In HEK293T cells, overexpression of
TRIM27 significantly reduced MDP-induced NOD2-mediated
NF-kB activation in a dose-dependent manner (Figure 6A). This
effect of TRIM27 on NOD2-mediated signaling cannot be
explained by inhibition of RIP2-NOD2 complex formation as
NOD2 was still able to bind RIP2 in the presence of TRIM27
(Figure S4A). Importantly, TRIM27 overexpression had no
significant influence on TNF-induced NF-kB activation
(Figure 6B). Moreover, NF-kB activation induced by overexpres-
sion of IKK-b was also not significantly influenced by TRIM27
(Figure 6C), suggesting that TRIM27 acts upstream of the IKK-
complex, likely at the level of NOD2.
Next, the effect of siRNA-mediated knock-down of endogenous
TRIM27 on NOD2-mediated signaling was determined in THP1
cells that have a functional endogenous NOD2 signaling pathway
[46] and express TRIM27 mRNA (Figure S2A). In line with a
function of TRIM27 in regulating NOD2 signaling, although not
significant, a tendency towards higher MDP-induced IL-8
secretion was observed with two different siRNAs tested (data
not shown). This suggests that other described negative regulators
of NOD2 can overcome missing regulation by TRIM27. Finally,
to explore if TRIM27 expression might be linked to NOD2-
associated diseases in vivo, we conducted immunohistological
inspection of colon sections derived from healthy and active
Crohn’s disease (CD) patients. This showed that TRIM27 was well
expressed in intestinal epithelial cells and to a lesser extent in cells
of the lamina propria. In all these cells TRIM27 exhibited a
primarily nuclear localization in these cells and appeared to be
restricted to sub-nuclear compartments (Figure 6D). Of note, the
TRIM27 signal appeared lower in healthy tissue compared to
tissue derived from active Crohn’s patients (Figure 6D). Analysis of
TRIM27 mRNA expression in colon biopsy material of Crohn’s
disease patients confirmed a significant increase in TRIM27
expression in CD compared to healthy controls (Figure 6E).
Collectively, these data support a role for TRIM27 as a specific
negative regulator of NOD2-mediated signaling and suggest a
implication of TRIM27 in Crohn’s disease.
Discussion
In this paper we report the identification of the E3 ubiquitin
ligase TRIM27 as a new interaction partner for NOD2. Mapping
studies indicated that NOD2 binds via its NBD domain to the
TRIM27 B30.2/PRY-SPRY domain. The B30.2 domain is
composed of the ,61 aa PRY and the ,140 aa SPRY domain
and is most commonly found at the C-terminus of TRIM proteins
[18]. The SPRY domain is evolutionarily more ancient as it is
found in animals, plants and fungi, whereas the B30.2 domain is
only found in vertebrates with an adaptive immune system [47]. In
humans, B30.2/PRY-SPRY domains are only present at the C-
terminus in TRIM proteins and in butyrophilin-related trans-
membrane glycoproteins (BTNs), which are receptors of the
immunoglobulin superfamily [48]. Of note, the TRIM27 binding
site for NOD2 correlates with the findings for other TRIM
proteins: TRIM21 binds its interaction partners IRF3 and IRF8
via the B30.2/PRY-SPRY domain [49–51] and TRIM25 binds
RIG-I via the C-terminal SPRY domain [52]. TRIM20 (also
known as pyrin), regulates caspase-1 activation and IL-1b
production by interacting with caspase-1 via its PRY-SPRY and
with ASC via its PYD domain, respectively [53–55]. Mutations in
the human TRIM20 PRY-SPRY domain are associated with
inherited Familial Mediterranean Fever (FMF). TRIM20 knock-in
mice expressing a TRIM20 with the mutant human PRY-SPRY
domain reflect the inflammatory phenotype found in patients by
mutant of TRIM27 were expressed together with NOD2 and HA-ubiquitin in HEK293T cells. Immunoprecipitates were probed with the indicated
antibodies. E) HEK293T cells expressing the indicated proteins were stimulated with 10 mM MDP for the indicated time. Lysates were subjected to
immunoprecipitation as described in (C). Densitometric analysis of the TRIM27 signal in the immunoprecipitation normalized to the input signal is
shown (bottom). Representative data of at least three independent experiments are shown.
doi:10.1371/journal.pone.0041255.g003
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forming spontaneous ASC-dependent, NLRP3-independent in-
flammasomes [56]. This clearly links the PRY-SPRY domain in
TRIM20 to immune functions. Another intriguing example
underscoring the involvement of PRY-SPRY domains in NLR
regulation is present in zebrafish (Danio rerio). One class of NLR
proteins in D. rerio comprises molecules harboring a PRY-SPRY
domain fused to the canonical NLR sequence [57]. Of note, PRY-
SPRY domains from D. rerio NLRs are closely related to zebrafish
TRIMs, indicating domain shuffling during evolution [58]. This
suggests that TRIM and NLR proteins have been tied together in
evolution to function in innate immune responses.
TRIM proteins are involved in the regulation of PRR- and IFN-
signaling pathways, typically by acting as ubiquitin ligases. TRIM-
mediated ubiquitination events have been documented to both
enhance immune response as shown i.e. for TRIM8, TRIM21,
TRIM23, TRIM25 and TRIM56 [49,51,52,59–61] or inhibit
them as shown for TRIM21 and TRIM30-a [50,62,63]. We show
here that also TRIM27 is involved in regulating PRR-signaling by
negatively regulating NOD2. We observed that NOD2 is
ubiquitinated by K48-linked ubiquitin chains and that this
ubiquitination is enhanced by TRIM27 overexpression, whereas
overexpression of an E3 ligase-deficient mutant of TRIM27
(TRIM27 E3) reduces NOD2 ubiquitination (Figure 4).
K48-linked ubiquitination usually targets proteins to degrada-
tion [40], which is partly mediated by TRIM proteins in PRR-
and IFN-signaling pathways: Mouse TRIM30-a promotes ubiqui-
tination and degradation – although not by proteasomal but rather
by lysosomal degradation – of TAB2 and TAB3 thereby inhibiting
TLR-induced NF-kB activation [63], whereas TRIM8 decreases
SOCS-1 protein levels leading to an inhibition of IFN-c-signaling
repression by SOCS-1 [59]. Ubiquitinated NOD2 is also targeted
to proteasomal degradation, as inhibition of the 26S proteasome
Figure 4. TRIM27 contributes to proteasomal degradation of NOD2. A) HEK293T cells transfected with low amounts of Flag-NOD2 and myc-
TRIM27, E3 or CTR as indicated were treated with 30 mg/ml cycloheximid (CHX) and immunoblots of total cell lysates (top) were performed using the
indicated antibodies. GAPDH served as loading control. B) HEK293T cells expressing the indicated proteins were treated with 100 nM bortezomib.
Lysates were subjected to immunoprecipitation as described in Figure 1A. Actin served as loading control. C) HEK293T cells transfected for 48 h with
siCTR, siTRIM27-1 or -3 and subsequently with Flag-NOD2 were treated with 30 mg/ml CHX, as indicated. Immunoblots of total cell lysates were
performed using the indicated antibodies. GAPDH served as loading control. Representative data of at least three independent experiments are
shown (see also Fig. S3B).
doi:10.1371/journal.pone.0041255.g004
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with bortezomib led to NOD2 protein stability and accumulation
of ubiquitinated NOD2 (Figure 4B). Of note, NOD2 protein
stability is effectively dependent on TRIM27. This is evidenced by
the finding that knock-down of endogenous TRIM27 as well as
overexpression of TRIM27 E3 inhibited NOD2 degradation
(Figure 4A and 4C). The latter indicates that TRIM27 E3 acts as
dominant negative over WT TRIM27 and endogenous TRIM27.
We were surprised that overexpression of TRIM27 did not
correlate with reduced NOD2 protein stability. Our interpretation
is that this might be due to the activity of endogenous TRIM27
that might be sufficient to target even ectopically expressed NOD2
efficiently for degradation or that degradation at the proteasome is
rate-limiting for overexpressed NOD2. TRIM27 has also been
shown to confer SUMO E3 ligase activity [29]. However, we did
not detect SUMOylated NOD2, suggesting that NOD2 might not
be a substrate for TRIM27-mediated SUMOylation (data not
shown). In most cases, proteins are ubiquitinated in the cytosol and
are degraded in this compartment. However, also evidence for
nuclear ubiquitination and protein degradation exists [64]. Based
on our results showing that only a small fraction of NOD2 seems
to shuttle to the nucleus (Figure 5) we suggest that NOD2 might be
ubiquitinated in the cytoplasm.
Regulation of PRRs by ubiquitination and proteasomal
degradation is a common theme for PRRs in animals and plants:
Figure 5. NOD2 WT localizes to the nucleus whereas NOD2 K305R or NOD1 do not. A) Indirect immunofluorescence micrographs of HeLa
cells grown on coverslips and expressing myc-NOD2 WT (top) or myc-NOD2 K305R (bottom) were treated with 50 nM leptomycine B (LMB) for 4 h or
left untreated. Images with signals for DAPI, TRIM27, myc-NOD2 and an overlay (blue: DAPI, red: TRIM27, green: NOD2) are shown. B) Quantification of
NOD2 subcellular localization in HeLa cells expressing Flag-NOD2 WT or K305R, as indicated (n = 100). Data is representative of two independent
experiments. C) Cellular fractions of HEK293T cells transfected with Flag-NOD1, -NOD2 WT or -NOD2 K305R, as indicated, and treated as described in
A were generated. Immunoblots of precipitated protein and total lysates are shown. For densitometric analysis, cytosolic and nuclear signals were
normalized to GAPDH and Lamin A/C, respectively. The ratio of nuclear to cytosolic protein is shown in fold. Representative data of at least three
independent experiments are shown. D) Indirect immunofluorescence micrographs of HeLa cells expressing untagged-NOD2 WT treated with 50 nM
leptomycine B (LMB) for 4 h or left untreated. Bars, 10 mm.
doi:10.1371/journal.pone.0041255.g005
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Figure 6. TRIM27 negatively regulates NOD2 signaling. A–C) NF-kB luciferase assays in HEK293T cells to determine the influence of TRIM27
overexpression on MDP-induced NOD2-mediated (A), TNF- (B), or IKK-b-induced (C) NF-kB activation. Normalized luciferase activity (nRLU) of
unstimulated (white bars) and stimulated (black bars) samples is shown. Values are given as mean+SD (n = 3). *, P,0.05; ***, P,0.005. D. Sections
from human colon derived from healthy and active Crohn’s disease patients. Staining with DAPI (blue), phalloidin-FITC (green) and with a-TRIM27
antibody (red) is shown. Staining with a rat serum is shown as control in the lower panel (rat serum). Slides are representative for 3 control and 4
Crohn’s disease patients. Scale bar = 20 mm. E. qRT-PCR of TRIM27 mRNA expression in colonic biopsies derived from patients with Crohn’s disease
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Triad3A is known to control TLR4 and TLR9 signaling [65] and
plant FLS2 has been shown to be ubiquitinated and degraded in a
negative feedback-loop by PUB12/13 [66]. Our data suggest that
NOD2 signaling is regulated in a similar manner. Indeed, gene
reporter assays in HEK293T cells showed that TRIM27
overexpression specifically reduces NOD2-mediated MDP-in-
duced NF-kB activation in a dose-dependent manner, whereas
TNF- and IKK-b-induced NF-kB activation is not affected. The
negative regulating effects of TRIM27 on NOD2 signaling are not
necessarily explained by NOD2 degradation but might also be due
to circumvention of adaptor protein recruitment to the NOD2
complex. However, TRIM27 did not inhibit NOD2-RIP2
interaction (Figure S4A). In contrast to our findings, Zha et al.
reported that TRIM27 interacts with IKK-a, IKK-b, IKK-e and
negatively regulates NF-kB, IFN-b and ISRE activation induced
by these kinases in a RING-domain-independent manner [36].
The discrepancies between the two data sets remain unclear and
need further independent investigation.
In contrast to most TRIM proteins, TRIM27 expression is not
altered in response to IFNs [16,17]. Among the TRIM proteins
induced by type I and II IFNs, many have been shown to confer
antiviral activity, although IFN-inducibility is not a prerequisite for
this [17,39]. Constitutively expressed TRIM proteins have also
been shown to trigger antiviral immune responses. TRIM27
overexpression, however, did not influence Sendai virus-induced
IFN-b activation (Figure S4B). We therefore assume that TRIM27
might predominantly function in other pathways including NOD2
signaling.
NOD2 has been reported to be localized in the cytosol and at
the cell membrane at steady-state conditions. Unexpectedly, we
found that ectopically expressed NOD2, in contrast to NOD1, can
shuttle to the nucleus (Figure 5), dependently on a functional
Walker A motif, i.e. ATPase activity. Although, a strong bipartite
nuclear localization signal (NLS) in the NOD2 sequence could not
be identified. Due to the low expression of endogenous NOD2, we
were not able to establish the sub-cellular localization of
endogenous NOD2. So although nuclear shuttling was verified
for both NOD2 and epitope-tagged versions of NOD2 ectopically
expressed in different cells by both cell biological and biochemical
techniques, we cannot formally exclude that this is a particularity
of ectopically expressed NOD2. Of note, also two other members
of the human NLR family are known to shuttle to the nucleus.
CIITA, one of the founding members of the NLR family, has long
been recognized to regulate MHC class II gene expression by
acting as a scaffold for DNA-binding transcription factor assembly
in the nucleus [67,68]. Recently, also NLRC5 has been shown to
localize to the nucleus and to regulate MHC class I expression
[44,45,69]. Of note, nuclear translocation and functionality are
also shown for several NLR-related plant R proteins. For tobacco
N, barley MLA, arabidopsis RPS4 and potato RX R proteins
nuclear localization is essential for defense activation [70–73]. For
these it has been suggested that pathogen recognition takes place
in the cytoplasm, whereas they act in the nucleus to induce
transcriptional reprogramming to activate immune responses [74].
This is exemplified by the tobacco N protein, which confers
resistance to Tobacco mosaic virus (TMV). Here MAP kinase
activation in the cytosol is necessary for N-mediated resistance in
addition to its nuclear functions [75,76]. In analogy, it is tempting
to speculate if NOD2 might not only recognize pathogens and
activate MAP kinases and NF-kB in the cytosol, but likely possess
additional nuclear functions to mediate and control immune
responses. TRIM27 is known to be recruited to specific subnuclear
compartments [33] and was suggested as a transcriptional
repressor [34,35]. This raises the intriguing possibility that
TRIM27, in addition to its role in NOD2 regulation, might be
functionally involved in orchestrating NOD2 nuclear functions.
Future research might help to address these open questions.
We and others recently demonstrated that some mutations in
the NBD domain of NOD2 can result in enhanced NF-kB
activation, whereas the corresponding mutations do not increase
the activity of NOD1 [77]. This suggests that NOD2 is more
prone for autoactivation compared to NOD1, requesting tighter
control mechanisms to act on NOD2 to prevent unwanted auto-
inflammatory responses. This is in line with the findings that I)
more negative regulators are reported for NOD2 than for NOD1
[78,79], II) there are more disease-associated mutations found in
NOD2 than in NOD1 [11], and III) NOD1 is expressed at basal
levels in most tissues whereas NOD2 expression is more restricted
and can be induced by pathogen stimuli [8,80–84]. Here, we add
another difference between NOD1 and NOD2 regulation and
show that NOD2, but not NOD1, is controlled by ubiquitination
and subsequent proteasomal degradation dependent on TRIM27
E3 ligase activity. We identified TRIM27 as a negative regulator
of NOD2-mediated inflammatory responses and detected en-
hanced TRIM27 expression in the colon of Crohn’s disease
patients. Clinically, this makes TRIM27 an interesting new target
for NOD2-associated diseases. It is conceivable that targeting
TRIM27 might be advantageous when NOD2 activity is altered,
such as in Crohn’s disease.
Materials and Methods
Plasmids
Plasmids encoding N-terminally Flag-tagged NOD1, NOD2
and deletion constructs of NOD2 (DCARD: aa250–1040; DLRR:
aa1–600; CARD: aa1–250; NBD: aa250–600; LRR: aa600–1040)
have been described [4,85]. Myc-NOD1 WT, myc-NOD2 WT
and K305R were obtained by subcloning (BamHI-XhoI) into a
modified pcDNA3.1 vector containing an N-terminal 3xmyc tag.
Human TRIM27 cDNA was obtained from ImaGenes (Berlin,
Germany) (GI 115387097). Full length TRIM27 and deletion
constructs (DRING: aa63–513; DRING+BBox: aa133–513;
DPRY-SPRY: aa1–295; PRY-SPRY: aa296–513) were generated
by PCR and cloned into pGEX-II (kindly provided by I. Roux,
Institute Pasteur, Paris) or a modified pcDNA3.1 vector (see
above). Point mutations of myc-TRIM27 E3 ligase mutant
(CC16/31AA) were generated by PCR mutagenesis according to
the QuikChange Site-Directed Mutagenesis procedure (Strata-
gene). IFN-b luciferase reporter was a kind gift from M. Schro¨der
(NUI Maynooth), IgK luciferase NF-kB-reporter and b-galacto-
sidase expression plasmid were described previously [4]. VSV-
tagged RIP2 was a kind gift from M. Thome (University
Lausanne). The IKK-b plasmid was purchased from InvivoGen.
pRK5-HA-ubiquitin (Addgene plasmid 17608) is described in
[86]. All constructs were subjected to full-length DNA sequencing.
Two-hybrid analysis
Binary two-hybrid screening was performed as described by
Gyuris et al. [87]. Briefly, the bait plasmids (pEG202) express the
cDNA fused directionally to the first 202 residues of LexA under
and controls (CTR) with no evidence of mucosal inflammation. Each symbol represents one patient. TRIM27 mRNA expression normalized to GAPDH
is shown. *, P,0.05 (n = 6).
doi:10.1371/journal.pone.0041255.g006
TRIM27 Regulates NOD2
PLoS ONE | www.plosone.org 10 July 2012 | Volume 7 | Issue 7 | e41255
the control of the constitutive ADH promoter. Prey plasmids
(pJG4-5) express the cDNA fused to the B42 activation domain,
the SV40T nuclear localization signal and an HA-tag under the
control of the inducible GAL1 promoter. EGY42/EGY48 diploid
strain was generated by mating for every pairwise combination.
Six LexA-operators lacZ in the pSH18-34 vector and a genome
integrated 4 LexA-operators LEU2 are used as reporters. The
expression of two reporters was used to establish the interaction,
blue-turning colonies and growth in the absence of Leu.
Cell culture and siRNA
HEK293T cells were kindly provided by the Sansonetti lab
(Institute Pasteur, Paris) [4], HeLa (ATCC #CCL-2) and SW480
(ATCC #CCL-228) cells were obtained from the ATCC. Cells
were cultivated at 37uC in a 5% CO2 atmosphere in Dulbecco’s
modified Eagle’s medium (Biochrom AG) supplemented with 10%
heat-inactivated fetal bovine serum (Biowest), penicillin and
streptomycin (100 IU/ml and 100 mg/ml, respectively; Biochrom
AG). Cells were continuously tested for absence of mycoplasma
contamination by PCR.
All siRNA duplexes were obtained from Qiagen: siCTR
(AllStars Negative Control, #1027281); siTRIM27-1 (target
sequence AAGACTCAGTGTGCAGAAAAG); siTRIM27-3 (tar-
get sequence CAGAACCAGCTCGACCATTTA, Hs_RFP_6,
SI03062794); siNOD2 (target sequence CTGCCACATGCAA-
GAAGTATA; Hs_CARD15_3, SI00133049); siRIP2 (target
sequence ACGTATGATCTCTCTAATAGA).
Co-immunoprecipitation and immunoblotting
For co-immunoprecipitations, HEK293T cells were seeded in
6 cm dishes and were transiently transfected with 1 mg plasmid as
indicated using Lipofectamin2000 (Invitrogen) or FuGene6
(Roche). Cells were lysed in NP40 buffer (150 mM NaCl,
50 mM Tris pH 7.4, 1% NP40) or RIPA buffer (150 mM NaCl,
50 mM Tris pH 7.4, 1% Triton X-100, 0.1% SDS, 0.5%
deoxycholate) containing phosphatase inhibitors (20 mM b-glyc-
erophosphate, 5 mM NaF, 100 mM Na3VO4) and protease
inhibitors (Complete protease inhibitor cocktail with EDTA;
Roche). Lysates were cleared for 20 min at 14,0006 g at 4uC.
Flag-tagged NOD2 was immunoprecipitated with anti-Flag beads
(M2 agarose; Sigma), myc-tagged TRIM27 with anti-myc beads
(c-myc AC, clone 9E10; Santa Cruz Biotechnology) for 3 h at 4uC.
Beads were washed five times with lysis buffer before SDS loading
buffer containing b-mercaptoethanol was added. Typically, 10-
times more precipitate than input was loaded onto the gel. Proteins
were separated by Laemmli sodium dodecylsulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) and subsequently transferred on
nitrocellulose membrane (Bio-Rad) by semi-dry immunoblotting.
Proteins were detected by incubation of the membrane successive
with primary and secondary antibody and a final incubation with
SuperSignal West Pico Chemiluminescent Substrate or Femto
Maximum Sensitivity Substrate (Pierce). Signals were recorded on
an electronic imaging system (LAS4000, Fujifilm). Primary
antibodies were mouse anti-Flag M2 (1:2000; Stratagene), rabbit
anti-myc (1:500; A-14, Santa Cruz Biotechnology), rabbit anti-
TRIM27 (1:400; IBL), rabbit anti-HA (1:500; Y-11, Santa Cruz
Biotechnology), mouse anti-ubiquitin (1:500; Santa Cruz Biotech-
nology), mouse anti-ubiquitin K48 (1:1000; Millipore), mouse anti-
ubiquitin K63 (1:1000; Millipore), rat anti-NOD2 4A11 (1:100;
[4]), rabbit anti-lamin A/C (1:500; Cell Signaling Technology),
rabbit anti-GAPDH (1:1000; Santa Cruz Biotechnology) and
rabbit anti-actin (1:1000; A2066, Sigma-Aldrich). Secondary
antibodies were horseradish peroxidase (HRP)-conjugated goat
anti-mouse IgG, light chain specific (1:4000; Jackson ImmunoR-
esearch Laboratories), HRP-conjugated goat anti-mouse IgG
(1:4000; 170-6516, Bio-Rad), HRP-conjugated goat anti-rabbit
IgG (1:4000; 170-6515, Bio-Rad) and HRP-conjugated goat anti-
rat IgG (1:4000; Jackson ImmunoResearch Laboratories). All
antibodies were diluted in 5% milk in PBS or TBS, according to
the manufacturer’s instructions.
Endogenous NOD2 was immunoprecipitated from SW480 cells
lysed in NP40 buffer using the NOD2 specific monoclonal rat
antibody 6F6 [6] bound to Protein-G Sepharose beads.
For testing for ubiquitination of NOD2, HEK293T cells were
lysed in NP40 buffer containing 1% SDS and boiled for 10 min.
Immunoprecipitations were conducted from these samples diluted
1:10 in NP40 buffer as described above.
Expression of recombinant GST-TRIM27
TRIM27 and its deletion constructs were expressed as N-
terminal glutathione S-transferase (GST) fusion proteins in
Rosetta2 (DE3) pLys E.coli cells (kindly provided by G. Praefcke)
following overnight isopropyl 1-thio-b-d-galactopyranoside (IPTG,
100 mM; Sigma) induction at 20uC. Bacteria were lysed by a
freeze-and-thaw cycle followed by addition of 1.5% sarkosyl
(Sigma) and sonication. All GST fusion proteins were purified
from bacterial extracts with glutathione-Sepharose (Amersham
Biosciences), followed by extensive washing with buffer A
(150 mM NaCl, 50 mM Tris pH 7.5, 2 mM DTT), buffer B
(500 mM NaCl, 50 mM Tris pH 7.5, 2 mM DTT) and again
buffer A. TRIM27 protein bound to glutathione-Sepharose was
stored in buffer A at 280uC.
In vitro translation and GST-binding assay
In vitro transcription/translation (IVT) of NOD2 was performed
from the Flag-NOD2 construct by T7 RNA polymerase (Promega)
in the presence of L-[35S]-methionine (10 mCi/ml; Perkin Elmer)
using the TnT coupled reticulocyte lysate system (Promega)
according to the manufacturer’s instructions. IVT preparation was
diluted three times in PBS and incubated with recombinant
TRIM27 protein bound to glutathione-Sepharose beads for 2 h at
4uC. Beads were precipitated and washed five times with RIPA
buffer (150 mM NaCl, 50 mM Tris pH 7.4, 1% Triton, 0.1%
SDS, 0.5% deoxycholate) before SDS loading buffer containing b-
mercaptoethanol was added. Proteins were analyzed by Laemmli
sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) followed by Coomassie brilliant blue staining. Autoradio-
graphs were recorded using a PhosphorImager (Bio-Rad).
Indirect immunofluorescence microscopy
For indirect immunofluorescence microscopy, HeLa cells were
seeded in 24-well plates on glass coverslips and transiently
transfected with 0.8 mg of expression plasmids, as indicated using
Lipofectamin2000 transfection reagent (Invitrogen) according to
the manufacturer’s instructions. After 24 h, cells were fixed with
3% paraformaldehyde (Roth) in PBS for 10 min and permeabi-
lized with 0.5% Triton X-100 (Roth) in cold PBS for 5 min. Cells
were blocked in 3% bovine serum albumin (BSA; Roth) in PBS for
20 min and incubated successively in primary and secondary
antibodies. Primary antibodies: rabbit anti-TRIM27 (1:500; IBL)
and mouse anti-myc (1:1000; 9E10, Sigma). Secondary antibody:
goat anti-rabbit AlexaFluor 546 (1:250; Invitrogen Molecular
Probes) and goat anti-mouse AlexaFluor 488 (1:250; Invitrogen
Molecular Probes). DNA was stained with DAPI (5 mg/ml;
Invitrogen Molecular Probes). Cells were mounted in ProLong
Gold antifade reagent (Invitrogen Molecular Probes). Image
acquisition of z-stacks was performed on an Olympus FV-1000
laser scanning microscope (objective: Olympus PlanApo, 606/
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1.40 oil, ‘/0.17) and images were processed using the ImageJ
software [88].
Sub-cellular fractionation
For fractionation, HEK293T cells were seeded in 10 cm dishes
and transiently transfected with 3 mg plasmid as indicated. After
24 h, cellular fractions were prepared using the Qproteome cell
compartment kit (Qiagen). Flag-tagged proteins in the different
fractions were precipitated using anti-Flag beads as described
above.
Luciferase reporter assay
36104 HEK293T cells per well were seeded in 96-well plates
and transfected with 8.6 ng b-galactosidase, 13 ng luciferase NF-
kB- or 10 ng IFN-b-reporter, different amounts of myc-TRIM27
and either with or without 0.1 ng NOD2 or 10 ng IKK-b
expression plasmids as indicated, added up with pcDNA to 51 ng
total DNA using FuGene6 (Roche). Cells were directly stimulated
with 50 nM MDP, 10 ng/ml TNF (all obtained from InvivoGen)
or 133 hemagglutination units (HAU)/ml Sendai virus (hen egg
allantoid fluid; obtained from Charles River Laboratories) or left
unstimulated, as indicated. After 16 h, cells were lysed in luciferase
lysis buffer (25 mM Tris pH 8, 8 mM MgCl2, 1% Triton, 15%
glycerol, 1 mM DTT) and luciferase activity was measured using a
standard plate luminometer. Standard deviation (SD) was
calculated from triplets and luciferase activity was normalized as
a ratio to b-galactosidase activity. All experiments were repeated
independently at least three times.
RT-PCR
End point RT-PCR was performed using Taq polymerase
(Fermentas) on cDNA obtained from isolated RNA of the
indicated cell lines. RNA was isolated using the RNeasy kit
(Qiagen) and 1 mg of total RNA was transcribed into cDNA using
the First Strand cDNA synthesis kit (Fermentas) with an oligo (dT)
primer (Fermentas). Primers for TRIM27 were obtained from
Qiagen (QT00051954). For GAPDH, the following primer pair
was used: GAPDH_fwd, GGTATCGTGGAAGGACTCAT-
GAC; and GAPDH_rev, ATGCCAGTGAGCTTCCCGTT-
CAG. The PCR products were separated by agarose gel
electrophoresis and visualized using ethidium bromide.
qRT-PCR of TRIM27 from patient samples
Endoscopic biopsies were taken from the sigmoid colon of
patients with mildly to moderately active Crohn’s disease and
controls. Only patients with no endoscopic or histological evidence
of mucosal inflammation were included in the control group.
Written informed consent was obtained from all patients before
endoscopy. The study was approved by the local ethical committee
of the University Hospital Aachen, Germany. Biopsies were
immediately shock-frozen in liquid nitrogen and stored at 280uC.
RNA from frozen tissue biopsies was isolated using PegGOLD
RNAPure (PEQLAB Biotechnology) according to the manufac-
turer’s instructions. 2 mg of RNA were treated with DNAseI
(Invitrogen) before cDNA was generated by reverse transcription
with 200 ng random hexamer primer (Invitrogen), 500 mM
dNTPs (Invitrogen) and 4 U Omniscript Reverse Transcriptase
(Quiagen) in 16reverse transcriptase buffer for 1 h at 37uC. Real-
time PCR was performed using Real Time PCR System 7300
(Applied Biosystems) and SYBRGreenER qPCR Super Mix
(Invitrogen). TRIM27 expression levels were normalized to
GAPDH. Primers for TRIM27 were obtained from Qiagen
(QT00051954). For GAPDH, the following primer pair was used:
GAPDH_fwd, CAGCCTCAAGATCATCAGCA; and
GAPDH_rev, CCTTCCACGATACCAAAGTTGTC.
Immunfluorescence microscopy of human specimens
Colon biopsies from Crohn’s disease and control patients were
obtained during colonoscopy surgeries and placed in Tissue-TekH
(Sakura Finetek Europe B.V, Netherlands). Frozen samples were
cut in 7 mm-sections and fixed with 4% paraformaldehyde for
15 minutes at 4uC. Slides were blocked for 1 hour with 50% (v/v)
fetal calf serum and 50% (v/v) PBS/BSA 1% at room
temperature. To assess TRIM27 expression anti-RET Finger
Protein (RFP) rabbit IgG affinity purified primary antibody
(0.1 mg/ml, IBL, Japan) and secondary Alexa Fluor 594 goat
anti-rabbit IgG (H+L) (1:200 dilution, Invitrogen, USA) were used.
F-Actin-staining was performed by using Phalloidin FITC labeled
mixed isomers (2 mg/ml in DMSO, Sigma-Aldrich). Slides were
mounted with Vectashield/DAPI stain (Vector Laboratories H-
1200) and stored at 4uC in darkness prior to immunfluorescence
microscopy. Images were captured with Zeiss AxioVision LE Rel.
4.4 on a Zeiss Axio Imager Z1 (Carl Zeiss Inc.) with a 206
objective.
Statistical analysis
Data are presented as mean+SD. Significance was assessed with
the two-sample Student’s t-test (*, P,0.05; **, P,0.01; ***,
P,0.005)
Supporting Information
Figure S1 Screening for TRIM proteins interacting with
NOD2. A. Results obtained from the Y2H screen using human
NOD2 full length (NOD2 fl) and several human TRIM proteins as
bait and prey, as indicated. x, weak interaction; ‘‘XX’’, strong
interaction. B. Characterization of the rat 6F6 anti-NOD2
antibody. Western blot probed with 6F6, loaded with different
amounts of whole cell lysates from SW480 cells and SW480 cells
treated with a NOD2 specific siRNA for 48 h is shown.
(TIF)
Figure S2 TRIM27 mRNA expression and cellular
localization. A. End-point RT-PCR analysis of TRIM27 mRNA
expression in different cell lines. Amplification of GAPDH served
as control. B. Indirect immunofluorescence micrographs of HeLa
and HEK cells grown on coverslips. Images with signals for DAPI,
TRIM27 and an overlay (blue: DAPI, red: TRIM27) are shown.
C. HeLa cells were stimulated with 10 mM MDP for 3 h or left
unstimulated. Cellular fractions were prepared using the Qpro-
teome cell compartment kit. Immunoblot analysis was performed
using the indicated antibodies. D. Indirect immunofluorescence
micrographs of HeLa cells grown on coverslips and expressing
myc-NOD1 were treated with 50 nM LMB for 4 h or left
untreated. Images with signals for DAPI, myc-NOD1 and an
overlay (blue: DAPI, green: NOD1) are shown. Bars, 10 mm.
(TIF)
Figure S3 NOD2 but not NOD1 is degraded. A. HEK cells
expressing Flag-NOD1 or –NOD2 were treated with 30 mg/ml
CHX, as indicated. Immunoblots of total cell lysates (top) were
performed using the indicated antibodies. GAPDH served as
loading control. Densitometric analysis (bottom) of the NOD1 and
NOD2 signals normalized to GAPDH is shown. B. HEK293T
cells transfected with Flag-NOD2 and myc-TRIM27, E3 or CTR
as indicated were treated with 30 mg/ml cycloheximid (CHX) and
immunoblots of total cell lysates (top) were performed using the
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indicated antibodies. GAPDH served as loading control (related to
Figure 4A).
(TIF)
Figure S4 Effect of TRIM27 on RIP2/Nod2 interaction
and IFN signalling. A. Lysates of HEK cells expressing the
indicated proteins were subjected to immunoprecipitation using
anti-Flag beads. Immunoblots of immunoprecipitates (IP) and total
lysates (Input) were performed using the indicated antibodies. B.
To determine the influence of TRIM27 on Sendai virus-induced
IFN-b promoter activation, HEK293T cells were transfected with
different amounts of TRIM27, as indicated, and an IFN-b
promotor luciferase reporter system. Cells were then infected with
133 HAU/ml Sendai virus. Normalized luciferase activity (nRLU)
is shown. Values are given as mean+SD.
(TIF)
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